Navigation Links
GEN co-sponsors roundtable discussion on novel bioremediation techniques
Date:12/7/2010

New Rochelle, NY, December 7, 2010Genetic Engineering & Biotechnology News (GEN) recently co-sponsored a roundtable discussion on new ways to use biological solutions to assist in environment clean-up after manmade or natural disasters. "Gulf Oil Spill: Using Modern-day Biology to Assess the Environmental Impact and to Help in Remediation" was also sponsored by the Venture Development Center (VDC) at The University of Massachusetts Boston, where the discussions took place. Part I of the roundtable appears on the Video Section of the GEN website (http://www.genengnews.com/video-channel) and a link to the entire roundtable presentation is also included on the GEN website Video Section.

"The Gulf Oil Spill catastrophe was a clear wake-up call regarding the critical need for faster, more efficient, and more environmentally-friendly clean-up solutions," said John Sterling, Editor in Chief of GEN, who served as co-moderator of the roundtable along with William Brah, Assistant Vice Provost for Research and Executive Director of the VDC. "GEN was honored to work with such a prestigious roundtable panel," added Sterling.

The panel members included John Farrington, UMass Dartmouth & Woods Hole Oceanographic Institute (Emeritus); Olivia Mason, Lawrence Berkeley National Laboratory; Doug Bartlett, Scripps Oceanographic Institute; Juanita Urban-Rich, UMass Boston; and Richard T. Schumacher, Pressure BioSciences, Inc. (NASDAQ:PBIO).

During the roundtable, scientists from academia and industry discussed the effectiveness of biological methods and tools that could help improve the understanding of the marine environment, assess the impact that oil spills of any magnitude have on this complex yet delicate ecosystem, and help monitor the effectiveness and even be part of the clean-up procedure during remediation.


'/>"/>

Contact: John Sterling
jsterling@genengnews.com
914-740-2196
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1

Related biology news :

1. University of Maryland co-sponsors International Conference on the Effects of Noise on Aquatic Life
2. Roundtable Concepts Inc., the Company that has Officially Licensed Marvel Comic TVs and Officially Licensed Collegiate TVs, has just Launched their Own Line of HDTVs Named RTC View
3. ACS Green Chemistry Institute Pharmaceutical Roundtable award goes to Scottish chemist
4. More talk, less agreement: Risk discussion can hurt consensus-building on science/technology
5. International discussions on FRAX smooth the way for implementation in clinical practice
6. Scientists identify novel inhibitor of human microRNA
7. Conaway Lab identifies novel mechanism for regulation of gene expression
8. LIAI launches new division to look at novel approaches to heart disease and inflammation
9. Childrens National researchers develop novel anti-tumor vaccine
10. Cold Spring Harbor Laboratory scientists trace a novel way cells are disrupted in cancer
11. Novel publishing approach puts textbook in more hands
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
GEN co-sponsors roundtable discussion on novel bioremediation techniques
(Date:7/9/2014)... are turning to more healthful alternatives to their savored ... mean low satisfaction. Now researchers are reporting new progress ... are made with olive oil rather than pork fat. ... Agricultural and Food Chemistry . , Ana M. Herrero ... expect just the right amount of chewiness and springiness, ...
(Date:7/9/2014)... on the verge of an economy driven by methane, the ... and is undergoing a production boom. It has poised the ... is casting serious doubts over just how climate-friendly it is, ... (C&EN), the weekly news magazine of the American Chemical ... at C&EN, explains that when burned as a fuel to ...
(Date:7/9/2014)... protect neuronal function and increase the survival rate ... her team, School of Pharmaceutical Sciences, Southwest University, ... mice were administered with low dose of levothyroxine ... aged rats exhibited an obvious improvement in cognitive ... to 93%. The underlying mechanism was demonstrated that ...
Breaking Biology News(10 mins):
... The first State of the Carbon Cycle Report for North ... Science Program, finds the continents carbon budget increasingly overwhelmed by ... tons of carbon into the atmosphere each year, mostly as ... may remove up to half this amount, but these current ...
... In the December 1st issue of G&D, Dr. Hailing ... of a new class of small RNAs in Arabidopsis. ... dubbed long short interfering RNAs (lsiRNAs), and are induced ... liRNAs share some hallmark features with other, previously identified ...
... Researchers from Kaiser Permanente and the California Department of ... nationwide, today will begin enrolling families in the largest ... that may cause autism and other developmental disabilities. ... Early Development, will involve 2,700 children and their parents ...
Cached Biology News:First-ever 'State of the Carbon Cycle Report' finds troubling imbalance 2Largest study to investigate risk factors of autism to begin enrolling families 2
(Date:1/15/2014)... 2014 This webinar will focus on ... safety assessment in biosimilars. , Regulatory frameworks are evolving ... development, however the complex nature of biopharmaceuticals makes the ... efficacy extremely challenging. Based on the specific aspects of ...
(Date:1/15/2014)... 2014 Two champions of science, technology, ... of an annual competition for middle and high school ... innovative STEM study. The competition presents students with real-world ... Engineering Aptitude, Mathematics, and Sciences is a program ...
(Date:1/15/2014)... January 15, 2014 2013 was a ... Brain State Technologies®. They saw continued independent research led ... who were awarded a $1 million grant from the ... “Brain and Behavior” a peer reviewed journal, Amy Grant ...
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... , SAN DIEGO, July 27 Neurocrine Biosciences (Nasdaq: NBIX ) ... Neurocrine Biosciences Webcast, When: July 30, 2009 ... Live over the Internet -- Simply log on to the web ... above., Contact: Jane Sorenson of Neurocrine Biosciences, +1-858-617-7653., , ...
... , , , ... (PTC) today announced the initiation of a Phase 2 clinical ... (NF2), a rare genetic disorder that causes the development of ... investigational new drug that is designed to selectively block tumor-related ...
... Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY ) announced ... SAFC Pharma(R), a Division of Sigma-Aldrich Corporation, it has ... under cGMP conditions. This run is anticipated to be ... the next several years as Oncolytics provides product for ...
Cached Biology Technology:PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 2PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 3PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 4Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R) 2
WD-repeat protein 4...
Rabbit polyclonal to MDM2 (phospho S185) ( Abpromise for all tested applications). entrezGeneID: 4193 SwissProtID: Q00987...
... human omental preadipocytes are ... otherwise healthy donors. There ... diabetic cells. Please inquire ... media also available. Academic ...
ASCIZ...
Biology Products: